Name | N-(1,3-Benzodioxol-5-ylmethyl)-N-methylacetamide |
---|---|
Synonyms |
Acetamide, N-(1,3-benzodioxol-5-ylmethyl)-N-methyl-
N-(1,3-Benzodioxol-5-ylmethyl)-N-methylacetamide MFCD20143110 |
Description | SY-640 is an Acetamide derivative and has potent hepatoprotective effect. SY-640 reduces Propionibacterium acnes and Lipopolysaccharide-induced liver injury in mice[1][2]. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | SY-640 inhibits the number of liver-infiltrating cells and attenuates the increased expression of leukocyte function-associated antigen-1 on these cells[1]. |
In Vivo | SY-640 (Oral; 150 mg/kg; once daily for 7 days) significantly inhibits Propionibacterium acnes and Lipopolysaccharide-induced liver injury, but a single administration is without effect[1]. SY-640 (p.o.; 150 mg/kg; once daily for three days) significantly increases the liver microsomal cytochrome P-450 content and aminopyrine demethylase activity in mice. The hepatic microsomal aminopyrine demethylase activity is obviously inhibited two hours after oral administration of SY-640[2]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 349.2±21.0 °C at 760 mmHg |
Molecular Formula | C11H13NO3 |
Molecular Weight | 207.226 |
Flash Point | 165.0±22.1 °C |
Exact Mass | 207.089539 |
LogP | 0.89 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.557 |